Short description
Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies that help save lives around the world.
Description
Covalon Technologies Ltd. (Covalon) is a medical device and biotechnology commercialization company. The Company is engaged in the business of developing, licensing and selling medical technologies. The Company operates in two segments: Advanced Wound Care and Specialized Medical Device Coatings. Its offices and laboratories are located in Mississauga, Ontario, Canada. Covalon sells its technologies to medical companies and distributors. Covalon’s antimicrobial technologies can be used for applications in areas, such as medical device coatings, wound care products, polymer mixes for extrusion, skin sanitizers, surface sanitizers, cosmetics, consumer products, veterinary applications, and others. Its products include ColActive, ColActive Ag, ColActive Plus, ColActive Plus Ag and CovaClear Ag. The Company’s wholly owned subsidiaries include Covalon Technologies Inc. and COV Healthcare Innovations Corp.
Last funding
Nopepepe
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Mississauga, Ontario, Canada, North America
Founded on
January 1, 2004
Exited on
January 7, 2005
Went public on
January 7, 2005
Stock symbol
COV
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$7890 - 12340
Sign in for full access
Founders
William Jackson